Drugmaker to Pay Maine $1.2 Million as Part of National Diabetes Drug Settlement
AUGUSTA ? Attorney General William J. Schneider has joined 37 other states in a $90 million settlement with GlaxoSmithKline LLC (GSK), resolving allegations that the pharmaceutical company unlawfully promoted its diabetes drug, Avandia, by misrepresenting its cardiovascular risks and safety profile.
The settlement will bring more than $1.2 million to the State of Maine.
?Patients rely on safety claims made by pharmaceutical companies,? said Attorney General Schneider. ?This settlement will help ensure that patients are not put at risk by misleading marketing.?